Your browser doesn't support javascript.
loading
mCRPC Patients Receiving 225Ac-PSMA-617 Therapy in the Post-Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis.
Sathekge, Mike; Bruchertseifer, Frank; Vorster, Mariza; Lawal, Ismaheel O; Knoesen, Otto; Mahapane, Johncy; Davis, Cindy; Mdlophane, Amanda; Maes, Alex; Mokoala, Kgomotso; Mathabe, Kgomotso; Van, Christophe; Wiele, de; Morgenstern, Alfred.
Afiliação
  • Sathekge M; Department of Nuclear Medicine; University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa; mike.sathekge@up.ac.za.
  • Bruchertseifer F; Nuclear Medicine Research Infrastructure, Pretoria, South Africa.
  • Vorster M; European Commission, Joint Research Centre, Karlsruhe, Germany.
  • Lawal IO; Department of Nuclear Medicine; University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa.
  • Knoesen O; Department of Nuclear Medicine; University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa.
  • Mahapane J; Nuclear Medicine Research Infrastructure, Pretoria, South Africa.
  • Davis C; Nuclear Technology Products, Pelindaba, South Africa.
  • Mdlophane A; Department of Nuclear Medicine; University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa.
  • Maes A; Department of Nuclear Medicine; University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa.
  • Mokoala K; Nuclear Medicine Research Infrastructure, Pretoria, South Africa.
  • Mathabe K; Department of Nuclear Medicine; University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa.
  • Van C; Katholieke University Leuven, Kortrijk, Belgium.
  • Wiele; Department of Nuclear Medicine; University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa.
  • Morgenstern A; Department of Urology; University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa; and.
J Nucl Med ; 63(10): 1496-1502, 2022 10.
Article em En | MEDLINE | ID: mdl-35177427

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: J Nucl Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: J Nucl Med Ano de publicação: 2022 Tipo de documento: Article